BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10690285)

  • 1. Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo.
    Piot CA; Martini JF; Bui SK; Wolfe CL
    Cardiovasc Res; 1999 Dec; 44(3):536-42. PubMed ID: 10690285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo.
    Holly TA; Drincic A; Byun Y; Nakamura S; Harris K; Klocke FJ; Cryns VL
    J Mol Cell Cardiol; 1999 Sep; 31(9):1709-15. PubMed ID: 10471354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat.
    Krupinski J; Ferrer I; Barrachina M; Secades JJ; Mercadal J; Lozano R
    Neuropharmacology; 2002 May; 42(6):846-54. PubMed ID: 12015211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1.
    Garnier P; Ying W; Swanson RA
    J Neurosci; 2003 Sep; 23(22):7967-73. PubMed ID: 12954857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
    Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
    Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway.
    Yadav SS; Sindram D; Perry DK; Clavien PA
    Hepatology; 1999 Nov; 30(5):1223-31. PubMed ID: 10534344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) polymerase activation and cell injury in the course of rat heart heterotopic transplantation.
    Fiorillo C; Pace S; Ponziani V; Nediani C; Perna AM; Liguori P; Cecchi C; Nassi N; Donzelli GP; Formigli L; Nassi P
    Free Radic Res; 2002 Jan; 36(1):79-87. PubMed ID: 11999706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of poly (ADP-ribose) polymerase inhibition against the reperfusion injury in heart transplantation.
    Fiorillo C; Ponziani V; Giannini L; Cecchi C; Celli A; Nediani C; Perna AM; Liguori P; Nassi N; Formigli L; Tani A; Nassi P
    Free Radic Res; 2003 Mar; 37(3):331-9. PubMed ID: 12688429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase.
    Liaudet L; Yang Z; Al-Affar EB; Szabó C
    Mol Med; 2001 Jun; 7(6):406-17. PubMed ID: 11474134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic preconditioning attenuates apoptotic cell death in the rat retina.
    Zhang C; Rosenbaum DM; Shaikh AR; Li Q; Rosenbaum PS; Pelham DJ; Roth S
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3059-66. PubMed ID: 12202530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion.
    Maulik N; Yoshida T; Engelman RM; Deaton D; Flack JE; Rousou JA; Das DK
    Mol Cell Biochem; 1998 Sep; 186(1-2):139-45. PubMed ID: 9774195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
    Kaplan J; O'Connor M; Hake PW; Zingarelli B
    Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of poly(ADP-ribose)polymerase-1 alters nuclear factor-kappa B activation and gene expression of apoptosis regulators after reperfusion injury.
    Zingarelli B; Hake PW; O'Connor M; Denenberg A; Kong S; Aronow BJ
    Mol Med; 2003; 9(5-8):143-53. PubMed ID: 14571322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury.
    Sodhi RK; Singh M; Singh N; Jaggi AS
    Arch Pharm Res; 2009 Jul; 32(7):1037-43. PubMed ID: 19641885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic preconditioning decreases apoptosis in rat hearts in vivo.
    Piot CA; Padmanaban D; Ursell PC; Sievers RE; Wolfe CL
    Circulation; 1997 Sep; 96(5):1598-604. PubMed ID: 9315553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Na+,K(+)-ATPase and Ca(2+)-ATPase activities in multi-cycle ischemic preconditioning in rabbit hearts.
    Yorozuya T; Adachi N; Dote K; Nakanishi K; Takasaki Y; Arai T
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):981-7. PubMed ID: 15519193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7.
    Germain M; Affar EB; D'Amours D; Dixit VM; Salvesen GS; Poirier GG
    J Biol Chem; 1999 Oct; 274(40):28379-84. PubMed ID: 10497198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
    Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
    J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.